Amy leads research and development at Life Edit Therapeutics. She has more than 20 years of scientific leadership and expertise with an extensive background in genetic medicine, neuroscience, drug development, and scientific strategy.
by
Heidi Wagner leads the Company’s global government affairs function, playing a key role in the continued national and global expansion of our technology platforms and biomanufacturing network. Heidi has more than 20 years of experience in establishing and executing global strategies across government affairs, public policy, and patient advocacy.
